Tivic Health Signs Distribution Agreement with Cardinal Health
27 Juni 2023 - 3:15PM
Business Wire
Tivic Health® Systems, Inc. (“Tivic”, “Company”, Nasdaq: TIVC),
a health tech company that develops and commercializes
bioelectronic medicine, today announced that the Company has
entered into a non-exclusive distribution agreement with Cardinal
Health (RGH Enterprises) for Tivic’s products.
Cardinal Health is a leading distributor and manufacturer of
medical products and services for healthcare facilities worldwide.
With the goal of improving the lives of people every day, Cardinal
Health supplies medical and laboratory products to nearly 90% of
U.S. hospitals, more than 60,000 U.S. pharmacies, and over 10,000
specialty physician offices and clinics. They provide in excess of
3.4 million patients with 46,000 home healthcare products, and
their digital ecosystem, which supports medication adherence,
currently reaches beyond 23 million patients and over 60
payers.
“Cardinal Health is a highly regarded name in the medical field.
Execution of this agreement is one of our key steps in expanding
distribution and marketing targeted at healthcare professionals,”
said Jennifer Ernst, CEO of Tivic. “We are pleased to be adding our
highly effective, clinically proven bioelectronic sinus device to
the Cardinal Health at-home portfolio.”
About Tivic
Tivic is a commercial health tech company advancing the field of
bioelectronic medicine. Tivic’s patented technology platform
leverages stimulation on the trigeminal, sympathetic, and vagus
nerve structures. Tivic’s non-invasive and targeted approach to the
treatment of inflammatory chronic health conditions gives consumers
and providers drug-free therapeutic solutions with high safety
profiles, low risk, and broad applications. Tivic’s first
commercial product ClearUP is an FDA approved, award-winning,
handheld bioelectronic sinus device. ClearUP is clinically proven,
doctor-recommended, and is available through online retailers and
commercial distributors. For more information visit
http://tivichealth.com @TivicHealth
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: the company’s financial condition;
the company’s ability to raise additional capital, if and when
necessary; clinical trial results for the company’s product
candidates; market and other conditions; supply chain constraints;
macroeconomic factors, including inflation; and unexpected costs,
charges or expenses that reduce Tivic’s capital resources. Given
these risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. For a discussion of
other risks and uncertainties, and other important factors, any of
which could cause Tivic’s actual results to differ from those
contained in the forward-looking statements, see Tivic’s filings
with the SEC, including, its Annual Report on Form 10-K for the
year ended December 31, 2022, filed with the SEC on March 31, 2023,
under the heading “Risk Factors”; as well as the company’s
subsequent filings with the SEC. Forward-looking statements
contained in this press release are made as of this date, and Tivic
Health Systems, Inc. undertakes no duty to update such information
except as required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230627498422/en/
Media Contact: Kayleigh Westerfield 949-632-3439
Kayleigh.Westerfield@tivichealth.com
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
Von Mai 2023 bis Mai 2024